Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

16.13 +0.55 (+3.53%)
Streaming Delayed Price Updated: 9:49 AM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 139,942
Open 16.00
Bid (Size) 16.13 (1)
Ask (Size) 16.17 (3)
Prev. Close 15.58
Today's Range 15.91 - 16.48
52wk Range 4.270 - 15.94
Shares Outstanding 144,311,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts
 
Via Benzinga

Performance

YTD
+160.6%
+160.6%
1 Month
+23.3%
+23.3%
3 Month
+45.8%
+45.8%
6 Month
+108.4%
+108.4%
1 Year
+225.9%
+225.9%

More News

Read More
United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
Earnings Scheduled For August 5, 2025
Via Benzinga
Adaptive Biotechnologies (NASDAQ:ADPT) Fits Minervini's Trend Template with Strong Growth Momentum
Via Chartmill
Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday
Via The Motley Fool
Adaptive (ADPT) Q2 Revenue Surges 36%
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
Via Benzinga
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
From Adaptive Biotechnologies
Via GlobeNewswire
Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet
Via Benzinga
Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts
Via Benzinga
ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A High-Growth Stock Meeting Minervini’s Trend Template
Via Chartmill
Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration
Via Benzinga
Topics Government
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
From Adaptive Biotechnologies
Via GlobeNewswire
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A Strong Growth Candidate Meeting Minervini’s Criteria
Via Chartmill
5 Analysts Assess Adaptive Biotechnologies: What You Need To Know
Via Benzinga
Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday
Via Benzinga
Adaptive Biotechnologies Reports First Quarter 2025 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire

Frequently Asked Questions

Is Adaptive Biotechnologies Corporation - Common Stock publicly traded?
Yes, Adaptive Biotechnologies Corporation - Common Stock is publicly traded.
What exchange does Adaptive Biotechnologies Corporation - Common Stock trade on?
Adaptive Biotechnologies Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Adaptive Biotechnologies Corporation - Common Stock?
The ticker symbol for Adaptive Biotechnologies Corporation - Common Stock is ADPT on the Nasdaq Stock Market
What is the current price of Adaptive Biotechnologies Corporation - Common Stock?
The current price of Adaptive Biotechnologies Corporation - Common Stock is 16.13
When was Adaptive Biotechnologies Corporation - Common Stock last traded?
The last trade of Adaptive Biotechnologies Corporation - Common Stock was at 10/15/25 09:49 AM ET
What is the market capitalization of Adaptive Biotechnologies Corporation - Common Stock?
The market capitalization of Adaptive Biotechnologies Corporation - Common Stock is 2.33B
How many shares of Adaptive Biotechnologies Corporation - Common Stock are outstanding?
Adaptive Biotechnologies Corporation - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.